These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Herpes simplex viruses: is a vaccine tenable? Whitley RJ; Roizman B J Clin Invest; 2002 Jul; 110(2):145-51. PubMed ID: 12122103 [No Abstract] [Full Text] [Related]
4. Preparation and efficacy of an inactivated subunit vaccine (NFUIBHK) against type 2 Herpes simplex virus infection. Skinner GR; Williams DR; Buchan A; Whitney J; Harding M; Bodfish K Med Microbiol Immunol; 1978 Nov; 166(1-4):119-32. PubMed ID: 214676 [TBL] [Abstract][Full Text] [Related]
7. Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine. Kitces EN; Morahan PS; Tew JG; Murray BK Infect Immun; 1977 Jun; 16(3):955-60. PubMed ID: 197013 [TBL] [Abstract][Full Text] [Related]
8. Expression and stability of herpes simplex virus antigens in Salmonella typhimurium. Bowen JC; Reddy RM; Alpar HO; Brown MR; Rouse BT Adv Exp Med Biol; 1995; 371B():1543-6. PubMed ID: 7502853 [No Abstract] [Full Text] [Related]
9. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines. Weinberg A; Merigan TC J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591 [TBL] [Abstract][Full Text] [Related]
10. Protectivity of herpes simplex virus antigens: studies in mice on the adjuvant effect of PICLC and on the dependence of protection on T cell competence. Hilfenhaus J; Christ H; Köhler R; Moser H; Kirchner H; Levy HB Med Microbiol Immunol; 1981; 169(4):225-35. PubMed ID: 6268955 [TBL] [Abstract][Full Text] [Related]
11. Preparation and efficacy of antiherpes type 1 and 2 subunit vaccines. Kavaklova L; Dundarov S; Andonov P; Bakalov B; Dundarova D; Brodvarova I Acta Virol; 1986 Sep; 30(5):402-10. PubMed ID: 2878588 [TBL] [Abstract][Full Text] [Related]
14. [Herpes simplex infections]. Kimmig W Z Hautkr; 1989 Apr; 64(4):266-8, 271. PubMed ID: 2544060 [TBL] [Abstract][Full Text] [Related]
15. Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine. Scriba M Med Microbiol Immunol; 1978 Nov; 166(1-4):63-9. PubMed ID: 214688 [TBL] [Abstract][Full Text] [Related]
16. Protection against ocular and cutaneous infection with herpes simplex virus type 1 by intragastric immunization with live virus. Irie H; Shimeld C; Williams N; Hill T J Gen Virol; 1993 Jul; 74 ( Pt 7)():1357-62. PubMed ID: 8393076 [TBL] [Abstract][Full Text] [Related]
17. Prospects for vaccines for herpes simplex viruses. Berman PW J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):226-30. PubMed ID: 2828443 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs. Bernstein DI; Miller RL; Harrison CJ J Infect Dis; 1993 Mar; 167(3):731-5. PubMed ID: 8382722 [TBL] [Abstract][Full Text] [Related]
19. [Development and study of an experimental herpesvirus vaccine]. Shubladze AK; Fomina AN; Levina DS; Davydova AA Vopr Virusol; 1976; (5):584-7. PubMed ID: 188256 [TBL] [Abstract][Full Text] [Related]
20. [Attenuation of the herpes simplex virus]. Iovlev VI Tr Inst Im Pastera; 1979; 53():103-6. PubMed ID: 233622 [No Abstract] [Full Text] [Related] [Next] [New Search]